Attitudes of physicians managing inflammatory bowel disease toward alterations of liver function tests: an Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) survey.

IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY
Nicola Pugliese, Cristina Bezzio, Stefano Festa, Flavio Andrea Caprioli, Sara Renna, Edoardo Vincenzo Savarino, Angela Variola, Massimo Claudio Fantini, Simone Saibeni, Ambrogio Orlando, Daniela Pugliese, Fabio Salvatore Macaluso, Davide Polverini, Arianna Dal Buono, Roberto Gabbiadini, Laura Loy, Alessio Aghemo, Alessandro Armuzzi
{"title":"Attitudes of physicians managing inflammatory bowel disease toward alterations of liver function tests: an Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) survey.","authors":"Nicola Pugliese, Cristina Bezzio, Stefano Festa, Flavio Andrea Caprioli, Sara Renna, Edoardo Vincenzo Savarino, Angela Variola, Massimo Claudio Fantini, Simone Saibeni, Ambrogio Orlando, Daniela Pugliese, Fabio Salvatore Macaluso, Davide Polverini, Arianna Dal Buono, Roberto Gabbiadini, Laura Loy, Alessio Aghemo, Alessandro Armuzzi","doi":"10.1097/MEG.0000000000003016","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Liver diseases are common in patients with inflammatory bowel disease (IBD). Little is known about how specialists perceive and manage liver enzyme abnormalities. This study investigates the current practice and educational needs of IBD specialists in the management of liver enzyme abnormalities.</p><p><strong>Methods: </strong>A 22-question web-based survey was distributed to members of the Italian Group for the study of IBD, covering their demographics, workplace features, and approaches to managing liver enzyme abnormalities in IBD patients.</p><p><strong>Results: </strong>The survey was completed by 205/439 (46.7%) respondents. The majority of respondents were over 45 years old (38.5%) and worked in Northern Italy (61%). Most were gastroenterologists (86%) practicing in public hospitals (45%), with 21.5% having a defined referral pathway to a dedicated liver unit for IBD patients. Ninety-seven percent of physicians reported regular monitoring of transaminases, while 88% also monitored gamma-glutamyl transpeptidase and 76% alkaline phosphatase (ALP). In cases of abnormal enzyme levels, over 70% reported ordering additional diagnostic tests independently, with notable heterogeneity in the thresholds used to trigger further investigation. The conditions most frequently suspected in cases of mild transaminase elevations were metabolic dysfunction-associated steatotic liver disease (71%) and drug-induced liver injury (17%). A significant proportion of physicians (57%) considered their training in managing liver enzyme abnormalities adequate but acknowledged the need for further educational opportunities. The main barrier identified was the lack of specific guidelines and actionable flowcharts (62%).</p><p><strong>Conclusion: </strong>This survey reveals heterogeneity in monitoring and management of liver enzyme abnormalities among IBD specialists. Most physicians recognize the need for improved training and specific guidelines.</p>","PeriodicalId":11999,"journal":{"name":"European Journal of Gastroenterology & Hepatology","volume":" ","pages":"930-934"},"PeriodicalIF":1.8000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Gastroenterology & Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MEG.0000000000003016","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Liver diseases are common in patients with inflammatory bowel disease (IBD). Little is known about how specialists perceive and manage liver enzyme abnormalities. This study investigates the current practice and educational needs of IBD specialists in the management of liver enzyme abnormalities.

Methods: A 22-question web-based survey was distributed to members of the Italian Group for the study of IBD, covering their demographics, workplace features, and approaches to managing liver enzyme abnormalities in IBD patients.

Results: The survey was completed by 205/439 (46.7%) respondents. The majority of respondents were over 45 years old (38.5%) and worked in Northern Italy (61%). Most were gastroenterologists (86%) practicing in public hospitals (45%), with 21.5% having a defined referral pathway to a dedicated liver unit for IBD patients. Ninety-seven percent of physicians reported regular monitoring of transaminases, while 88% also monitored gamma-glutamyl transpeptidase and 76% alkaline phosphatase (ALP). In cases of abnormal enzyme levels, over 70% reported ordering additional diagnostic tests independently, with notable heterogeneity in the thresholds used to trigger further investigation. The conditions most frequently suspected in cases of mild transaminase elevations were metabolic dysfunction-associated steatotic liver disease (71%) and drug-induced liver injury (17%). A significant proportion of physicians (57%) considered their training in managing liver enzyme abnormalities adequate but acknowledged the need for further educational opportunities. The main barrier identified was the lack of specific guidelines and actionable flowcharts (62%).

Conclusion: This survey reveals heterogeneity in monitoring and management of liver enzyme abnormalities among IBD specialists. Most physicians recognize the need for improved training and specific guidelines.

治疗炎症性肠病的医生对肝功能检查改变的态度:意大利炎症性肠病研究小组(IG-IBD)调查
背景:肝脏疾病在炎症性肠病(IBD)患者中很常见。对于专家如何感知和处理肝酶异常,我们知之甚少。本研究调查了目前IBD专家在处理肝酶异常方面的实践和教育需求。方法:一项包含22个问题的基于网络的调查被分发给IBD研究意大利组的成员,包括他们的人口统计、工作场所特征和IBD患者肝酶异常的处理方法。结果:调查完成率为205/439(46.7%)。大多数受访者年龄在45岁以上(38.5%),在意大利北部工作(61%)。大多数是在公立医院执业的胃肠病学家(86%)(45%),其中21.5%的人有明确的转诊途径,可转诊到IBD患者的专门肝脏部门。97%的医生报告定期监测转氨酶,而88%的医生也监测γ -谷氨酰转肽酶和76%的碱性磷酸酶(ALP)。在酶水平异常的病例中,超过70%的患者报告单独订购了额外的诊断测试,用于触发进一步调查的阈值具有显著的异质性。在轻度转氨酶升高的病例中,最常怀疑的情况是代谢功能障碍相关的脂肪变性肝病(71%)和药物性肝损伤(17%)。相当大比例的医生(57%)认为他们在处理肝酶异常方面的培训是足够的,但承认需要进一步的教育机会。确定的主要障碍是缺乏具体的指导方针和可操作的流程图(62%)。结论:本调查揭示了IBD专科医生在监测和管理肝酶异常方面的异质性。大多数医生认识到需要改进培训和制定具体的指导方针。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.40
自引率
4.80%
发文量
269
审稿时长
1 months
期刊介绍: European Journal of Gastroenterology & Hepatology publishes papers reporting original clinical and scientific research which are of a high standard and which contribute to the advancement of knowledge in the field of gastroenterology and hepatology. The journal publishes three types of manuscript: in-depth reviews (by invitation only), full papers and case reports. Manuscripts submitted to the journal will be accepted on the understanding that the author has not previously submitted the paper to another journal or had the material published elsewhere. Authors are asked to disclose any affiliations, including financial, consultant, or institutional associations, that might lead to bias or a conflict of interest.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信